Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pharmacology of dipeptidyl peptidase-4 inhibitors and its use in the management of metabolic syndrome: a comprehensive review on drug repositioning.

Daru : journal of Faculty of Pharmacy, Tehran University of Medical Sciences·2019
Same author

Curcumin in tissue engineering: A traditional remedy for modern medicine.

BioFactors (Oxford, England)·2018
Same author

Down-regulation of CatSper 1 and CatSper 2 genes by lead and mercury.

Environmental toxicology and pharmacology·2018
Same author

Effect of Crocin on Antibody Titers to Heat-Shock Protein 27 in Subjects with Metabolic Syndrome.

Current clinical pharmacology·2017
Same author

Hypoxia in Atherogenesis.

Angiology·2016
Same author

Combination of Serum Interleukin-1β and 6 Levels in the Diagnosis of Perinatal Asphyxia.

Archives of Iranian medicine·2016

Related Experiment Video

Updated: Jul 2, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Multiple step-variable pathway hypothesis: a reason why predictions fail in atherosclerosis.

Gordon A A Ferns1

  • 1Postgraduate Medical School, University of Surrey, Guildford, Surrey GU2 7WG, United Kingdom. g.ferns@surrey.ac.uk

Medical Hypotheses
|September 3, 2008
PubMed
Summary

Cardiovascular risk factors alone poorly predict events. Identifying

Related Experiment Videos

Last Updated: Jul 2, 2026

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice
09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

Area of Science:

  • Cardiovascular science and disease progression modeling.

Background:

  • Individual cardiovascular risk factors have limited predictive power for adverse events.
  • Current risk prediction algorithms miscategorize a substantial portion of the population, leading to suboptimal management.

Purpose of the Study:

  • To propose a new hypothesis for atherogenesis, viewing it as a multi-step process.
  • To suggest that critical transitions in atherogenesis are driven by 'bundles' of risk factors, which may vary between individuals and stages.

Main Methods:

  • Conceptual framework based on multi-step atherogenesis.
  • Hypothesizing stage-dependent impact of risk factors and varying intervention efficacy.
  • Proposing the need for disease staging via imaging and functional assessment.

Main Results:

  • The impact of specific cardiovascular risk factors is non-uniform throughout atherogenesis.
  • The effectiveness of interventions is likely stage-dependent.
  • Risk assessment, even with complex algorithms, remains inherently imprecise.

Conclusions:

  • Targeting factors that promote specific stages of atherogenesis may reveal new therapeutic avenues.
  • Disease staging is potentially crucial for optimizing cardiovascular treatment efficacy.
  • Accurate cardiovascular risk stratification remains a significant challenge.